Institutional Ownership Nuvectis Pharma, Inc. (NVCT)
This table provides information about the institutional ownership of Nuvectis Pharma, Inc. (NVCT). We have compiled data on the 32 institutions that hold shares in the stock, with a total of 1.9 Million shares, which have been reported (via 13F filing form) to have a value of $12.8 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Ronit Capital LLP
|
Nov 04, 2022 Q3 2022 |
562,547
shares
|
$3.76 Million
5.37% of portfolio
|
Q3 2022
Added 34.17%
|
|
|
Baldwin Brothers LLC
|
Jan 22, 2025 Q4 2024 |
355,961
shares
|
$2.38 Million
0.01% of portfolio
|
Q4 2024
Added 104.42%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
325,297
shares
|
$2.18 Million
0.0% of portfolio
|
Q4 2024
Added 8.02%
|
|
|
Marshall Wace, LLP
London, X0 |
Feb 13, 2025 Q4 2024 |
124,571
shares
|
$833,379
0.0% of portfolio
|
Q4 2024
Added 190.96%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
83,412
shares
|
$558,026
0.0% of portfolio
|
Q2 2024
Reduced 77.62%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
79,243
shares
|
$530,135
0.0% of portfolio
|
Q4 2024
Reduced 0.59%
|
|
|
Forbes J M & CO LLP
|
Jan 28, 2025 Q4 2024 |
59,000
shares
|
$394,710
0.03% of portfolio
|
Q4 2024
Added 21.9%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Feb 14, 2025 Q4 2024 |
45,607
shares
|
$305,110
0.0% of portfolio
|
Q4 2024
Added 72.34%
|
|
|
Gsa Capital Partners LLP
London, X0 |
Feb 07, 2025 Q4 2024 |
34,751
shares
|
$232,484
0.01% of portfolio
|
Q4 2024
Reduced 30.68%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Feb 14, 2025 Q4 2024 |
30,594
shares
|
$204,673
0.0% of portfolio
|
Q4 2024
Added 36.38%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
29,698
shares
|
$198,679
0.0% of portfolio
|
Q4 2024
Reduced 56.64%
|
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
25,725
shares
|
$172,100
0.0% of portfolio
|
Q4 2024
Added 68.66%
|
|
|
Oppenheimer & CO Inc
New York, NY |
Feb 04, 2025 Q4 2024 |
25,000
shares
|
$167,250
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
22,000
shares
|
$147,180
0.0% of portfolio
|
Q4 2024
Added 43.79%
|
|
|
Squarepoint Ops LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
19,071
shares
|
$127,584
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Two Sigma Investments, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
18,570
shares
|
$124,233
0.0% of portfolio
|
Q4 2024
Reduced 30.67%
|
|
|
Edmond De Rothschild Holding S.A.
Chambesy, V8 |
Feb 12, 2025 Q4 2024 |
15,170
shares
|
$101,487
0.0% of portfolio
|
Q4 2024
Reduced 20.87%
|
|
|
Baxter Bros Inc
|
Feb 11, 2025 Q4 2024 |
15,000
shares
|
$100,350
0.01% of portfolio
|
Q4 2024
Added 20.0%
|
|
|
Nations Financial Group Inc,
Cedar Rapids, IA |
Jan 30, 2025 Q4 2024 |
13,500
shares
|
$90,315
0.01% of portfolio
|
Q4 2024
Added 35.0%
|
|
|
Cubist Systematic Strategies, LLC
Stamford, CT |
Feb 14, 2025 Q4 2024 |
6,294
shares
|
$42,106
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Point72 Asia (Singapore) Pte. Ltd.
Singapore, U0 |
Feb 14, 2025 Q4 2024 |
4,479
shares
|
$29,964
0.01% of portfolio
|
Q4 2024
New holding
|
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
2,669
shares
|
$17,855
0.0% of portfolio
|
Q4 2024
Added 24163.64%
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
2,319
shares
|
$15,514
0.0% of portfolio
|
Q4 2024
Reduced 1.24%
|
|
|
Bank Of America Corp
Charlotte, NC |
Feb 14, 2025 Q4 2024 |
1,615
shares
|
$10,804
0.0% of portfolio
|
Q4 2024
Added 112.5%
|
|
|
Barclays PLC
London, X0 |
Feb 13, 2025 Q4 2024 |
1,144
shares
|
$7,653
0.0% of portfolio
|
Q3 2024
Reduced 86.17%
|